The goal of the Pediatric Cancer Genetics Program is to provide individuals with information and guidelines based on their family history and/or genetic test results that will help in the prevention and early detection of cancer.
For more information
Genetics and Cancer Risk
Researchers estimate that about 8.5 to 10 percent of childhood cancers are due to hereditary factors.
Genetic testing may identify a hereditary cancer syndrome in a child, and could:
- Answer why a child developed cancer
- Guide screening for other cancers
- Guide treatment strategies
- Identify other family members at risk for cancer/other medical conditions
How Can Genetic Counseling Help Families?
A Genetic Counselor
Wants to listen and understand what patients and families are going through - to help them make decisions. The genetic counselor may:
- Conduct a genetic risk assessment
- Discuss genetic testing
- Determine how patients and families perceive cancer risk
- Discuss emotional well-being
- Ask about family dynamics and support system
- Provide helpful resources
- Discuss future health concerns
Our program is led a genetic counselor who specializes in the discovery and explanation of a child’s personal and/or family history as it relates to their diagnosis of cancer.
The genetic risk assessment conducted by the genetic counselor may determine whether the child has a personal or family history associated with a hereditary cancer syndrome.
Genetic counseling can help parents and families make informed decisions regarding testing, treatments and future plans.
Possible Reasons for Referral
- Acute Myeloid Leukemia
- Adrenocortical carcinoma
- Atypical teratoid or rhabdoid tumor
- Basal cell carcinoma
- Cardiac rhabdomyoma
- Colon polyps or adenocarcinoma
- Choroid plexus carcinoma
- Desmoid tumor
- Endolymphatic sac tumors
- Family history of cancer diagnosed at a young age
- Malignant nerve sheath tumors
- Ovarian sertoli-leydig cell tumors
- Optic pathway glioma
- Pituitary blastoma
- Pleuropulmonary blastoma
- Thyroid carcinoma
- Wilms tumor